GSK-7227
Product Specifications
CAS Number
1067214-81-6
Target
Dehydrogenase|||PPAR|||PDK|||CPT
Related Pathways
DNA Damage/DNA Repair|||PI3K/Akt/mTOR signaling|||Metabolism
Purity
0.9917
Bioactivity
GSK-7227, a novel compound representing a novel class of peroxisome proliferator-activated receptor delta (PPAR?) partial agonists, demonstrates potent partial agonistic activity by upregulating the expression of PPAR? target genes, specifically carnitine palmitoyltransferase 1a (CPT1a) and pyruvate dehydrogenase kinase 4 (PDK4), in cultured skeletal muscle cells, indicating its potential role in modulating skeletal muscle metabolism and energy homeostasis.
Smiles
O=C(O)C1=CC(=CC=C1NC(=O)C2=CC=CC(=C2)S(=O)(=O)N3C=CC=4C3=CC=C(OC)C4C)C
Molecular Formula
C25H22N2O6S
Molecular Weight
478.52
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1251223-01 0.02 mg (E-Coli)
Recombinant Brucella canis UPF0434 protein BCAN_B0909 (BCAN_B0909)
Ask
View Details 
MBS1251223-02 0.1 mg (E-Coli)
Recombinant Brucella canis UPF0434 protein BCAN_B0909 (BCAN_B0909)
Ask
View Details 
MBS1251223-03 0.02 mg (Yeast)
Recombinant Brucella canis UPF0434 protein BCAN_B0909 (BCAN_B0909)
Ask
View Details MBS1251223-04 0.1 mg (Yeast)
Recombinant Brucella canis UPF0434 protein BCAN_B0909 (BCAN_B0909)
Ask
View Details MBS1251223-05 0.02 mg (Baculovirus)
Recombinant Brucella canis UPF0434 protein BCAN_B0909 (BCAN_B0909)
Ask
View Details MBS1251223-06 1 mg (E-Coli)
Recombinant Brucella canis UPF0434 protein BCAN_B0909 (BCAN_B0909)
Ask
View Details